Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?

• Main Authors: Landgraf Jeanne M (Author), Arnold L Eugene (Author), Bukstein Oscar G (Author), Hodgkins Paul (Author)
• 格式: 圖書
• 出版: BMC, 2009-12-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>To evaluate health-related quality of life (HRQL) and medication satisfaction after switching from a stable dose of oral extended-release methylphenidate (ER-MPH) to methylphenidate transdermal system (MTS) via a dose-transition sche...